FILTERED RESULTS
FILTERS
•
·
·
FILTERED RESULTS
Nvidia buys stakes in four French tech startups, Les Echos reports
Edison shares on watch after short seller alleges fire liability risk
Minutes of the Board's discount rate meetings on August 17, September 9, and September 16, 2026
Lagarde Faces ECB Staff Questions Over Book, Talks With Fink
Bond Strategist Warns of Major Selloff if U.S. Treasury Yields Reach 6%
Asia Cements Lead in Cocoa Demand Revival in Uncertain Market
Iran's Navy Chief Issues Warning to US Ships in Hormuz Strait
Qualcomm says jury found Arm breached license agreement
Arm shares fall after jury rules in favor of Qualcomm in license dispute
Ukrainian President Proposes New Talks with the United States
Netanyahu and Trump Discuss Potential Military Action Against Iran
India’s Top Diplomat Encouraged by US Talks, Defends Russia Ties
Bond Traders Eclipsed by Equities in a Wall Street Reversal
S&P 500 Slips as Chipmaker Selloff Overshadows Bank Earnings
‘Pro-business’ Burnham reassures chief executives on tax
Why is Vertex Pharmaceuticals stock sliding 4% today?
Why is Molina Healthcare stock up 3.5% today?
Jaishankar: India-US Trade Talks Heading in Right Direction
Long-Term Treasuries Rise Ahead of Key US Inflation Report
USDCAD Experiences Volatility as Sellers Regain Control
Why is Archer-Daniels-Midland stock rallying today?
Why is Chevron stock climbing to an all-time high today?
Grains and Oilseeds Muted Ahead of USDA Report on US Harvest
The Deal with Alex Rodriguez and Jason Kelly | Season 4B Trailer
QNBFS named ‘Best Equity Broker in Qatar for 2025’ by AFCM
Boeing delivers 57 jets in September
Goldman Sachs earnings analysis: questions answered and next catalysts
US blockade cuts Iranian crude exports to zero in October - report
EPA proposes higher biofuel blending for large refiners
Will bank earnings growth become a thing of the past?
Agribusiness expansion driving Qatar hospitality supply chain resilience, says trader
Apple Introduces HomeView, a $299 Tablet for the Home
EPA Proposes 100% Reallocation for Refinery Biofuel Breaks
Banking watchdogs ramp up AI scrutiny as stability fears mount
Ray Dalio Warns Slump in Treasuries Market Has ‘Long Way to Go’
Bond Traders Eclipsed by Equities in Rare Wall Street Reversal
Why is Amer Sports stock rallying today?
Amer Sports gains as Jefferies initiates at Buy citing Salomon, Arc’teryx momentum
European Stock Indices Close Mostly Lower Amid Middle East Tensions
NVIDIA to Invest $2 Billion in European AI Initiatives
Applied Materials shares slide as chip equipment outlook remains uncertain
Why is MongoDB stock rallying today?
US Treasury yield peak still ahead as Fed likely to tighten again, PIMCO’s Ivascyn says
S&P’s Blistering Earnings Momentum Is Getting Hard to Sustain
Trump Issues Warning to Houthis Amid Rising Oil Prices and Attacks on Saudi Arabia
Exclusive-Banking watchdogs ramp up AI scrutiny as stability fears mount, sources say
U.S. stocks slip slightly on tech weakness; Dow turns negative amid bank earnings
Hammack: explaining Fed moves is accountability via transparency
Anthropic to Host Institutional Investor Day Ahead of Potential IPO
AI Selloff Drags Emerging Stocks Down, Weighs on Currency Gauge
Wall Street plays down investor fears of faltering trading boom
US Senate report says spending on consultants for internet subsidy program tops $200 million annually
Explaining Fed moves is accountability via transparency – Hammack
Trump Considers Decisions on Iran and Yemen Response
S&P 500 Slips as Chipmaker Selloff Deepens, Banks Report Results
English football on ‘edge of financial disaster’, warns game’s new regulator
FTC says ‘pharma bro’ Martin Shkreli repeatedly violated industry ban
English Football Faces Financial Ruin, New UK Regulator Reports
Colombia: Villamizar de BanRep ve período prolongado de tasas altas
Martin Shkreli violated lifetime pharma industry ban, FTC and states say
US grocer Albertsons pulls annual outlook, accelerates turnaround efforts
US Treasury yields yet to peak as Fed may tighten further, PIMCO’s Ivascyn says
AI models may soon self-replicate across smart-home devices, Anthropic warns
USD/CHF Currency Pair Remains Range-Bound Amid Market Uncertainty
OpenAI Executive Warns of Potential Undetected Rogue AI Incidents
HID Joins FIDO Alliance Board to Promote Passwordless Authentication
B2PRIME Group Expands Institutional Liquidity Management Tool
United States Continues Intelligence Sharing with Ukraine
Tesla, Xpeng Showcase Autonomous Cars in Paris
Walmart Expands Employee Health Benefits to Include Diabetes Medications
Walmart has announced that it will provide certain diabetes medications at no cost to its employees. This initiative includes coverage for Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, both of which are used to treat Type 2 diabetes. The decision follows the implementation of a new prior authorization process aimed at improving access to these essential medications.
This expansion of benefits reflects Walmart's commitment to supporting the health and well-being of its workforce. By eliminating out-of-pocket costs for these medications, the company aims to alleviate financial burdens for employees managing chronic health conditions. The move is part of a broader strategy to enhance employee health benefits and promote better health outcomes.
© 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.
Source: KLEA News